Apton Biosystems, Inc. is a biotechnology company based in Pleasanton, California, specializing in advanced molecular diagnostics and genomic analysis. The company focuses on developing innovative solutions for high-throughput sequencing and other applications in the life sciences sector. Apton's technology aims to enhance the accuracy and efficiency of genetic testing, contributing to advancements in personalized medicine and research. Their commitment to innovation positions them as a key player in the evolving landscape of biotechnology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#60 in Pleasanton, CA

#7,118 in California

#29,882 in US

#56,092 in the World

Pleasanton, CA, United States of America

Apton Biosystems, Inc.

Forward Citations = 111

12 inventors:

Bryan P Staker (10 out of 47 patents)

Niandong Liu (9 out of 13 patents)

Michael David McLaughlin (5 out of 18 patents)

4. Bart Lee Staker (5 out of 6 patents)

5. Windsor Owens (5 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apton Biosystems, Inc.. Retrieved from https://idiyas.com/company/apton-biosystems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]